why choose us

First received: August 11, 2023

Clinical Trial: Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Obstructive Sleep Apnea

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Single-Arm, Safety and Efficacy Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea

Brief Summary: The goal of this clinical trial is to test the automatic positive airway pressure (APAP) function of the RXiBreeze PAP System in adult subjects with obstructive sleep apnea (OSA).The main questions the study aims to answer are:Is apnea-hypopnea index (AHI) detection using the RXiBreeze PAP System equivalent to apnea-hypopnea index (AHI) detection using PSG?What is the responder rate using the RXiBreeze PAP System?Participants will use the APAP function of the RXiBreeze PAP System while undergoing polysomnography…

Read more